Spirometry in Children at Six Months After SARS-CoV-2 Infection: A Single-Center Study

Pothireddy Sharanya1, Devendra Mishra1, Anurag Agarwal1

  • 1Department of Pediatrics, Maulana Azad Medical College and associated Lok Nayak Hospital, Delhi.

Indian Pediatrics
|October 12, 2023
PubMed

Insights

One-third of children experienced abnormal lung function, specifically reduced forced vital capacity and forced expiratory volume, six months after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Underweight children had higher odds of these abnormal spirometry results.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can impact various organ systems.
  • Long-term respiratory sequelae in children post-SARS-CoV-2 infection require further investigation.
  • Spirometry is a key tool for assessing lung function.

Purpose of the Study:

  • To evaluate spirometry parameters in children six months after severe SARS-CoV-2 infection.
  • To identify potential risk factors associated with abnormal lung function post-SARS-CoV-2.

Main Methods:

  • A single-center descriptive study involving 40 children (aged 7-18 years) six months post-SARS-CoV-2 infection.
  • Spirometry was performed to measure forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1).
  • Clinical history and examination were recorded; statistical analysis identified associations with spirometry results.

Main Results:

  • Thirty percent (12/40) of children exhibited abnormal spirometry (FVC <80%), with 83.3% of those also having FEV1 <80%.
  • Underweight children had significantly higher odds of abnormal spirometry (OR 5.13, P=0.028).
  • No significant association was found between abnormal spirometry and age, sex, infection severity, or oxygen requirement.

Conclusions:

  • Abnormal spirometry findings were present in one-third of children at the six-month follow-up after SARS-CoV-2 infection.
  • Underweight status is a potential risk factor for impaired lung function post-SARS-CoV-2 in children.
  • Further research is needed to understand the long-term respiratory implications of SARS-CoV-2 in pediatric populations.
Abstract

Related Concept Videos

Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
348
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
218
Respiratory Volumes and Capacities I01:26

Respiratory Volumes and Capacities I

Assessing the respiratory rate and rhythm for a complete minute is crucial for evaluating the breathing pattern. Even a minor increase in the patient's average respiratory rate, by as little as three to five breaths per minute, is an early and vital indicator of respiratory distress. Patients with a respiratory rate exceeding twenty-four breaths per minute require close monitoring to determine the physiological alterations. This careful observation is essential for prompt recognition and...
1.0K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
309